- Home
- LPTH vs MREO Comparison
LPTH vs MREO Comparison
Compare LPTH & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- MREO
- Stock Information
- Founded
- LPTH 1985
- MREO 2015
- Country
- LPTH United States
- MREO United Kingdom
- Employees
- LPTH N/A
- MREO N/A
- Industry
- LPTH Semiconductors
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- MREO Health Care
- Exchange
- LPTH Nasdaq
- MREO Nasdaq
- Market Cap
- LPTH 377.5M
- MREO 311.8M
- IPO Year
- LPTH 1996
- MREO N/A
- Fundamental
- Price
- LPTH $7.23
- MREO $1.84
- Analyst Decision
- LPTH Strong Buy
- MREO Strong Buy
- Analyst Count
- LPTH 3
- MREO 5
- Target Price
- LPTH $10.33
- MREO $7.40
- AVG Volume (30 Days)
- LPTH 1.9M
- MREO 1.6M
- Earning Date
- LPTH 11-11-2025
- MREO 11-10-2025
- Dividend Yield
- LPTH N/A
- MREO N/A
- EPS Growth
- LPTH N/A
- MREO N/A
- EPS
- LPTH N/A
- MREO N/A
- Revenue
- LPTH $43,860,530.00
- MREO $500,000.00
- Revenue This Year
- LPTH $62.13
- MREO N/A
- Revenue Next Year
- LPTH $22.15
- MREO $72.16
- P/E Ratio
- LPTH N/A
- MREO N/A
- Revenue Growth
- LPTH 36.85
- MREO N/A
- 52 Week Low
- LPTH $1.40
- MREO $1.47
- 52 Week High
- LPTH $10.69
- MREO $4.29
- Technical
- Relative Strength Index (RSI)
- LPTH 45.19
- MREO 45.03
- Support Level
- LPTH $6.81
- MREO $1.65
- Resistance Level
- LPTH $8.30
- MREO $1.93
- Average True Range (ATR)
- LPTH 0.76
- MREO 0.12
- MACD
- LPTH -0.14
- MREO -0.02
- Stochastic Oscillator
- LPTH 19.33
- MREO 36.00
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).